Immune response of BV-2 microglial cells is impacted by peroxisomal beta-oxidation.

"the data discussed in this publication have been deposited in ncbi's gene expression omnibus (edgar et al ) and are accessible through geo series accession number gse200022 ( https://www ncbi nlm nih gov/geo/query/acc cgi?"

"Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The authors warmly acknowledge the Fondation Maladies Rares, which supported our transcriptomic analysis project (GenOmics: High throughput sequencing and rare diseases, call 2017-20170615). Sequencing was performed by the GenomEast platform, a member of the France Génomique consortium (ANR-10-INBS-0009). The authors would like to acknowledge the Canadian New Frontiers Research Funds Exploration (NFRF-E 19-00007) and the regional council of Bourgogne Franche-Comté (Project PERSIL 2019) for their support. We are also grateful for the networking support by the COST Action CA 16,112 NutRedOx (Personalized Nutrition in aging society: redox control of major age-related diseases), supported by COST (European Cooperation in Science and Technology). This study was supported by institutional grants from INSERM, CNRS, and Aix-Marseille University to the CIML and a program grant from the French National Research Agency (ANR-17-CE15-0032). The project leading to this publication has received funding from the Excellence Initiative of Aix-Marseille University—A*MIDEX, a French Investissements d'Avenir program. Part of this research was also funded by grants from the Institut National de la Santé et de la Recherche Médicale (INSERM) and by a French Government grant managed by the French National Research Agency under the program “Investissements d'Avenir” with reference ANR-11 LABX-0021 (Lipstic Labex). The laboratory BioPeroxIL was funded by the Ministère de l'Education Nationale, de l'Enseignement Supérieur et de la Recherche (France), and by the University of Bourgogne. MT-J was funded by CNRST (PhD excellence grant number: 17UHP2019, Morocco) and by the Action Intégrée of the Comité Mixte Inter-Universitaire Franco-Marocain (no. TBK 19/92 no. Campus France: 41501RJ) from the PHC Toubkal program, Ministère des Affaires Étrangères. IW was supported by the Austrian Science Fund KLI 837-B and by the European Leukodystrophy Association (ELA) Germany."